WorldWideScience

Sample records for vozrasta litievykh pegmatitov

  1. Primenenie kombinirovannykh oral'nykh kontratseptivov u zhenshchin reproduktivnogo vozrasta s ozhireniem

    Directory of Open Access Journals (Sweden)

    E N Andreeva

    2009-06-01

    Full Text Available This article assesses the problem of obesity as a risk factor for development of severe metabolic complications and different disorders of reproductive function in women of childbearing age. It is pointed that obesity is associated with high prevalence of hyperandrogenemic and hyperplastic disorders, polycystic ovary syndrome, infertility, complications of pregnancy and childbirth. Article discusses the questions of integrated treatment approach of this category of patients, which include non-drug interventions (rational nutrition, lifestyle modification as well as the use of medications which lower the insulin resistance and hyperinsulinemia to restore ovary function and the possible use of combined oral contraceptives for correction of anovulation.

  2. Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout

    Directory of Open Access Journals (Sweden)

    V A Nasonova

    2007-09-01

    Zaklyuchenie. Chastota vyyavleniya u bol'nykh podagroy MS i IR ne zavisit ot vozrasta. Polucheny dannye, svidetel'stvuyushchie o nalichii vozrastnykh osobennostey MS u bol'nykh podagroy: u molodykh bol'nykh nablyudaetsya bol'shaya vyrazhennost' ozhireniya i gipertriglitseridemii, u pozhilykh narastaet chastota arterial'noy gipertenzii i giperglikemii.

  3. Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout

    Directory of Open Access Journals (Sweden)

    V A Nasonova

    2007-01-01

    Zaklyuchenie. Chastota vyyavleniya u bol'nykh podagroy MS i IR ne zavisit ot vozrasta. Polucheny dannye, svidetel'stvuyushchie o nalichii vozrastnykh osobennostey MS u bol'nykh podagroy: u molodykh bol'nykh nablyudaetsya bol'shaya vyrazhennost' ozhireniya i gipertriglitseridemii, u pozhilykh narastaet chastota arterial'noy gipertenzii i giperglikemii.

  4. Glucocorticosteroid-induced osteoporosis: pathogenesis, prevention, treatment

    Directory of Open Access Journals (Sweden)

    I A Baranova

    2008-01-01

    Full Text Available Glyukokortikoidindutsirovannyy osteoporoz (GIO - odno iz naibolee tyazhelykh oslozhneniy dlitel'noy (bolee 3 mes sistemnoy terapii glyukokortikoidami (SGK. On razvivaetsya u bol'nykh lyubogo vozrasta i pola i yavlyaetsya naibolee chastoy sistemnoy formoy vtorichnogo osteoporoza (OP. Bystraya poterya kostnoy massy proiskhodit uzhe v pervye mesyatsy lecheniya SGK. Perelomy ot minimal'noy travmy voznikayut pri bolee vysokikh pokazatelyakh mineral'noy plotnosti kosti, chem u bol'nykh pervichnym OP. Dazhe ispol'zovanie malykh doz SGK privodit k povysheniyu riska perelomov, s uvelicheniem sutochnoy dozy risk perelomov vozrastaet. U patsientov, primenyayushchikh vysokie dozy ingalyatsionnykh GK (IGK, uvelichenie riska OP i perelomov v bol'shey stepeni obuslovleno tyazhest'yu respiratornogo zabolevaniya, chem terapiey IGK. Predstavleny sovremennye printsipy profilaktiki i lecheniya GIO.